Multinational firms calls for review of massive drug price cut plan

Published: 2011-11-02 06:58:00

Updated: 2011-11-02 06:58:00

The Korean Research based Pharmaceutical Industry Association (KRPIA) announced Tuesday that the government’s plan to cut drug prices by an average of 14 percent starting next year should be reviewed again among related interest parties, claiming that the measure will affect the development of th...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK